You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter covering the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays.
Sarah Todd’s MAHA snackdown article highlights creative food marketing terms like “fibermaxxing” chips, “protein-powered” yogurt, and “longevity” beverages. For context, millennials’ most notable contribution to food marketing was light beer.
Send news tips and brand management schemes to [email protected] or Signal at John_Wilkerson.07.
Medicare’s Shift on Obesity Drugs After BALANCE Pilot Fails
The Trump administration’s attempt to provide affordable obesity drugs to seniors through the Medicare pilot program BALANCE fell short. Insurers did not participate as expected, prompting the administration to pivot to a new approach.
Medicare will now make these obesity drugs available to seniors outside the Part D drug benefit through a new pilot program called Bridge.
Continue to STAT+ to read the full story.
Related articles
Do 'Blue Zones' Really Prove Longevity? Experts Weigh the Science
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Shelley Wood and Eric Topol. Be sure to sign up for t...
Marty Makary's FDA Resignation Highlights Agency Turmoil Amid Leadership Shifts
On Tuesday, Food and Drug Administration Commissioner Marty Makary resigned from his position, leaving a vacancy at the top of the agency to match the...
Health Policy Experts Analyze Vaccines, Vaping, Drug Costs, and TrumpRx on Major Networks
KFF Health News chief Washington correspondent Julie Rovner discussed federal policy on vaccine research, vaping, and drug access on Science Friday on...
Robert F. Kennedy Jr. Balances Vaccine Skepticism with Ohio Outreach Tour
Here in Washington, we’ve been hearing about tensions between the White House and one of its most controversial — but, at least in some circles, most...
Takeda to Pay $13.6M for Alleged Kickbacks to Doctors Prescribing Antidepressant
Takeda Pharmaceuticals agreed to pay $13.6 million to settle allegations that it paid kickbacks to doctors to prescribe an antidepressant and, consequ...
GLP-1 Drugs Linked to Better Breast Cancer Outcomes in Obesity and Diabetes Patients
A recent study shows that GLP-1 drugs may help improve survival rates in people with breast cancer, obesity, and diabetes. Image Credit: Tatsiana Volk...
UK Political Shake-Up Could Reshape Global Drug Pricing Policies
Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. Congrats on...
U.S. Pressures Germany on Drug Prices Amid FDA Restructuring Concerns
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about we...